Feasibility of a Memory Support System for Mild Cognitive Impairment
Implementation of the Memory Support System: A Feasibility Study
This study is testing a new Memory Support System to see if it can help people with mild cognitive impairment and their caregivers manage daily activities and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Bruyère Health Research Institute. Academic / other |
| Locations | 1 site (Ottawa, Ontario) |
| Trial ID | NCT05999929 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the feasibility of implementing the Memory Support System (MSS) for individuals with mild cognitive impairment (MCI) and their care partners at a clinic in Ontario, Canada. Participants will complete a survey to express their interest and preferred methods for MSS administration, followed by training sessions for a selected group. The study will evaluate various outcomes, including program adherence, self-reported daily living activities, memory self-efficacy, quality of life, mood, anxiety, and caregiver burden. Data will be collected at baseline, post-treatment, and at an 8-week follow-up to inform future MSS implementation.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 50 and older diagnosed with mild cognitive impairment who have regular contact with a care partner.
Not a fit: Patients with significant visual or hearing impairments or those currently participating in another related clinical trial may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance cognitive support and quality of life for patients with mild cognitive impairment and their caregivers.
How similar studies have performed: While similar interventions have been explored, this specific approach to implementing the MSS is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of single or multi-domain MCI * Clinical Dementia Rating global (CDR) score of ≤ 0.5 * Montreal Cognitive Assessment score of ≥18 * available contact with a care partner ≥ 2 times weekly * absence or stable intake of nootropic(s) for ≥ 3 months Exclusion Criteria: * visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training * concurrent participation in another related clinical trial
Where this trial is running
Ottawa, Ontario
- Bruyère Health Research Institute — Ottawa, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Neil Thomas, MD — Bruyère Health Research Institute.
- Study coordinator: Neil Thomas, MD
- Email: nthomas@bruyere.org
- Phone: 613-562-6322
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.